导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.21% | 700/4773 |
| 近一周 | -0.98% | 1466/5465 |
| 近一月 | -1.81% | 1316/5421 |
| 近一季 | -1.57% | 1234/5231 |
| 近半年 | 6.94% | 732/4920 |
| 近一年 | 16.87% | 714/4394 |
| 近两年 | 75.60% | 911/2954 |
| 近三年 | 62.09% | 453/2253 |
| 成立以来 | 120.02% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.14% 1626/4961 |
18.41% 1381/5312 |
- - |
- - |
| 2025 | 30.45% 1318/4813 |
5.38% 785/3635 |
1.83% 2107/4076 |
21.35% 1813/4524 |
0.18% 2152/4813 |
| 2024 | 13.19% 1166/3463 |
5.20% 392/2808 |
1.01% 513/3014 |
11.61% 2491/3129 |
-4.55% 2477/3463 |
| 2023 | -10.10% 1266/2656 |
2.15% 1429/2280 |
-4.87% 1312/2385 |
-4.13% 1072/2515 |
-3.51% 710/2655 |
| 2022 | -16.85% 521/2207 |
-8.93% 302/1919 |
5.94% 807/2016 |
-12.10% 643/2113 |
-1.97% 1762/2208 |
| 2021 | 25.89% 106/1822 |
7.30% 74/1255 |
5.48% 807/1330 |
9.23% 140/1466 |
1.83% 785/1822 |
| 2020 | 38.91% 343/1250 |
-3.35% 298/1028 |
21.70% 226/1067 |
14.91% 250/1164 |
2.77% 967/1184 |
| 2019 | - - |
- - |
- - |
- - |
7.07% 491/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 鹏扬中证500质量成长ETF联接C VS. 长安沪深300非周期A(740101) |